Advancing global programmatic management of latent tuberculosis infection for at risk populations

Affiliations

¹ Global TB Programme, World Health Organisation, Geneva, Switzerland getahunh@who.int.
² WHO Collaborating Centre for TB/HIV and TB Elimination, University of Brescia, Brescia, Italy.
³ MRC Clinical Trials Unit and Centre for Infectious Disease Epidemiology, UCL, London, UK.
⁴ Respiratory Infections Unit, Dept for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
⁵ Dept of Infectious Diseases Galliera Hospital, Genoa, Italy.
⁶ WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy.

Free article

Editorial

Haileyesus Getahun et al. Eur Respir J. 2016 May.

Free article

. 2016 May;47(5):1327-30.

doi: 10.1183/13993003.00449-2016.

¹ Global TB Programme, World Health Organisation, Geneva, Switzerland getahunh@who.int.
² WHO Collaborating Centre for TB/HIV and TB Elimination, University of Brescia, Brescia, Italy.
³ MRC Clinical Trials Unit and Centre for Infectious Disease Epidemiology, UCL, London, UK.
⁴ Respiratory Infections Unit, Dept for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
⁵ Dept of Infectious Diseases Galliera Hospital, Genoa, Italy.
⁶ WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy.

No abstract available

Comment on

Monitoring latent tuberculosis infection diagnosis and management in the Netherlands.
Erkens CG, Slump E, Verhagen M, Schimmel H, de Vries G, Cobelens F, van den Hof S. Erkens CG, et al. Eur Respir J. 2016 May;47(5):1492-501. doi: 10.1183/13993003.01397-2015. Epub 2016 Feb 25. Eur Respir J. 2016. PMID: 26917614